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The human demyelinating disorder, progressive antigen primarily in cells of a neural crest origin (Beggs
et al., 1990) and develop distinct neuroectodermal tumorsmultifocal leukoencephalopathy (PML), is attributed to a
lytic infection of myelin-producing oligodendrocytes by and/or a hypomyelinated phenotype (Small et al.,
1986a,b; Trapp et al., 1988).the human polyoma JC virus (JCV) (reviewed in Frisque
and White, 1992; Major et al., 1992). Like other polyoma Promoter swapping experiments (between SV40 and
JCV) in transgenic mice revealed that the restricted glialviruses, JCV has a closed, circular, supercoiled double-
stranded DNA genome. The JCV genome can be structur- specificity may be largely attributed to the JCV promoter,
rather than the viral T-antigen (Feigenbaum et al., 1992).ally divided into three functional regions—the early cod-
ing region (encoding the regulatory proteins, the large T, Transient transfection analyses have shown that the ex-
pression of the viral early promoter is substantially higherand the small t antigens) located on the proximal side
of the replication origin, the late coding region (encoding in glial cells than in nonglial cells. (Feigenbaum et al.,
1987; Kenney et al., 1984; Lashgari et al., 1989; Nakshatrithe structural proteins VP1, VP2, and VP3 and the agno-
protein) located on the distal side of the replication origin, et al., 1990; Tada et al., 1989). In vitro transcription analy-
ses also corroborate the higher expression level in glialand the noncoding or regulatory region (containing the
origin of viral DNA replication and the transcriptional cells (Ahmed et al., 1990a). Further, both DNA replication
and late gene transactivation have been shown to occurcontrol region) that lies between the two coding regions
(Fig. 1A) (Frisque and White, 1992). The JCV noncoding in nonglial cells, when the JCV early proteins were pro-
vided (Feigenbaum et al., 1987; Lashgari et al., 1989).region functions in opposite orientations to regulate ex-
pression from the early and late gene coding regions. Together, these observations indicate that neurotropism
of JCV is largely a determinant of the restricted expres-This review offers a comprehensive guide to the tran-
scriptional regulation of JCV gene expression. sion of the viral early promoter. Further, the unique char-
acteristics of the viral T-antigen may also serve as addi-
tional specificity determinants (Lynch and Frisque, 1991;REGULATION OF JCV EXPRESSION
Tavis and Frisque, 1991).
JCV can be described as a fastidious virus: it displays
Additionally, somatic hybrid studies demonstrated a
a narrow species- and tissue-tropism, with efficient virion
dramatic extinction of the expression of the viral early
production seen only in human fetal glial cells (reviewed
gene product in transformed hamster glial cells, upon
in Major et al., 1992; Walker and Frisque, 1986). The
fusion with mouse fibroblast cells (Beggs et al., 1988).
restricted CNS tropism of both viral gene expression and
Assuming that the expression of the viral early gene
virus-induced pathology is also seen in experimental ani-
product is primarily under the control of the JCV early
mals. Inoculation of JCV into neonatal hamsters or owl
promoter in the transformed hamster glial cells, the data
monkeys precedes the development in these animals of
implicate a duality of the restriction of JCV transcription,
CNS tumors, including medulloblastomas, glioblasto-
with positive cellular regulators in glial cells and negative
mas, and neuroectodermal tumors (reviewed in Major et
cellular factors in nonglial cells.
al., 1992). Transgenic mice with the JCV T-antigen under
the control of the viral early promoter express the T- ANALYSES OF THE ROLE OF cis ELEMENTS ON
THE VIRAL PROMOTER
Since most of the in vivo analyses detailed above were1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (215) 923-5905. performed with the prototypical JCV Mad-1 strain, this
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new nomenclature system for the distinct regions and
elements on the viral promoter and in doing so, have
attempted to minimize changes from the published litera-
ture (Fig. 2).
Classic molecular techniques have been used in order
to identify and delineate the functional importance of
various regions on the viral promoter. DNase I foot-
printing experiments have detected protection over sev-
eral regions, including B, C, and D on the viral promoter,
with nuclear extracts from various cell lines, primary cul-
tures, or mouse brain (Amemiya et al., 1989, 1992; Nak-
shatri et al., 1990; Tamura et al., 1988a,b). Additional
protection was seen over the TATA box (Nakshatri et al.,
1990), as well as over the NF-kB element (R. Reddy et al.,
in preparation). A schematic representing the cumulative
areas of protection is depicted (Fig. 2), with protected
regions potentially playing a role in the expression of JCV
promoter. It can be argued that the in vitro footprinting
analyses may be an indication of potential rather than
real interactions with transcription factors that are abun-
dant in the nuclear extract rather than in the nucleus.
Further, since various regions of the viral promoter may
be single stranded or possess altered secondary struc-
tures (Amirhaeri et al., 1987), the double-stranded confor-
mation used for the DNase I footprinting experiments
may not accurately depict the conformation of the DNA
during transcription. Perhaps in vivo footprinting analy-
ses need to be performed to more accurately reflect the
promoter occupancy. Deletion analyses, site-directed
mutagenesis, and heterologous promoters have also
aided examinations of the functional importance of vari-
ous promoter regions. The transcriptional contribution of
each region, compiled from published reports, is individ-
ually detailed below.
FIG. 1. Map of the JCV MAD-1 genome (A). The numbers within the
The NF-kB element 5*-GGGAATTTCC-3* (sequencesinside circle represent the map positions, with 0.0 being the EcoRI site
5059–5069) (Major et al., 1990) has been shown to confer(Frisque et al., 1984). The shaded arrows depict the coding regions for
various virally encoded proteins, with numbers reflecting their positions an increase in basal transcriptional activity to JCV pro-
on the genome. The outside circle highlights the noncoding or regula- moters in either orientation in glial cells in transient trans-
tory region of the viral genome. Reported transcription initiation sites fection experiments (Ranganathan and Khalili, 1993).
for the early (B) and late (C) phases of the viral lytic cycle are also
Site-directed mutagenesis of the NF-kB element corrobo-portrayed (Daniel and Frisque, 1993; Khalili et al., 1987; Vacante et al.,
rates a role for this element as an activator of basal1989).
transcription (R. Reddy et al., in preparation). More im-
portantly, the NF-kB site provides the JCV promoter with
an inducible element that results in a dramatically higherreview is largely confined to the promoter analyses of
this well-characterized strain. Data from other JCV iso- level of promoter activity upon phorbol ester treatment
(Raj and Khalili, 1994; Ranganathan and Khalili, 1993).lates are included where appropriate.
The JCV promoter contains two characteristic tandem The ‘‘O’’ region (nt 5120–11) encompasses the core
origin of JCV viral DNA replication (Lynch and Frisque,98-bp repeats and functions in opposite orientations to
regulate the early and late gene expression (Fig. 1A). 1990) and shows a high (88%) homology with the SV40
core origin (Frisque et al., 1984). The viral T-antigen bindsDistinct transcription initiation start sites have been de-
tected from the viral promoter in the early (Fig. 1B) and here and initiates bidirectional replication. This region
also contains the major transcription initiation site for thein the late phase of infection (Fig. 1C) (Daniel and
Frisque, 1993; Khalili et al., 1987; Vacante et al., 1989). early genes (Daniel and Frisque, 1993; Khalili et al., 1987;
Vacante et al., 1989). This region includes the OGRS ele-Computer-aided analyses of the viral promoter indicate
the presence of several transcription factor binding sites ment with five copies of GGM repeats (M  A or C), and
by itself does not appear to significantly affect the basalin and around the 98-bp repeats (Fig. 2). We propose a
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FIG. 2. Structural organization of the viral transcriptional control region. The schematic in the center of the figure illustrates the structural
organization of the JCV promoter region, with boxed 98-bp repeats and motifs representing binding sites for both potential and known transcription
factors. The DNase I footprint pattern is cumulative and depicts areas of protection as darkly shaded regions between the lighter boxes representing
unprotected regions. Potential transcription factor binding sites are derived from computer-aided analyses, utilizing the SignalScan software program
(GenBank). The nomenclature for the regions and elements on the viral promoter represent a minimal departure from the reported names. Transcrip-
tion factors that have been shown to bind to the viral promoter are identified as known factors, while those known only by their sizes are depicted
as known protein sizes. Additional elements, including the HIV-1 Tat responsive elements, the viral T-antigen binding sites, and the viral origin of
DNA replication, are also exhibited.
transcriptional level of either the JCV promoter or a heter- transcription from the JCV late promoter does not appear
to be significantly dependent on the A region, as indi-ologous thymidine kinase promoter (Chowdhury et al.,
1993; Raj and Khalili, 1994). The O region, however, may cated by deletion analyses (Tada et al., 1991). In addition
to the AT, the A region contains Ap , which has beenbe crucial for induced levels of transcription, as the OGRS
element represents both an HIV-1 Tat-responsive ele- shown to confer increased transcription activity to cellu-
lar promoters (Struhl, 1985), as well as the binding sitement and a phorbol ester-responsive element (Chowd-
hury et al., 1993; Raj and Khalili, 1994). for the Tst-1 transcription factor (Wegner et al., 1993).
The ‘‘B’’ region (sequences 29–70 and 27–168) con-The ‘‘A’’ region (sequences 12–29 and 110–127) repre-
sents an A/T-rich stretch, containing both a TATA box tains three distinct functional elements, designated as
Bpenta (29–39), BNF-1 (39–54), and BAP-1 (54–69). Several(AT) and a poly(A) tract (Ap) (Fig. 2). Evidence for a func-
tional TATA box is indirect and derived from the identifi- published reports indicate that this region is consistently
protected in DNase footprinting experiments (Amemiyacation of a major early transcription initiation site 20 bp
downstream of the TATA box (Ahmed et al., 1990a; Daniel et al., 1989, 1992; Atwood et al., 1992; Kumar et al., 1993;
Nakshatri et al., 1990; Tada et al., 1989; Tamura et al.,and Frisque, 1993; Khalili et al., 1987; Tamura et al.,
1988a; Vacante et al., 1989). However, additional early 1988a,b). The B region appears to play an important role
in directing increased expression of the viral early pro-transcription initiation sites have been reported (Kenney
et al., 1986; Khalili et al., 1987; Krebs et al., 1995; Mandl moter in glial cells and decreased expression in nonglial
cells (Ahmed et al., 1990a; Tada et al., 1989).and Frisque, 1986; Tada and Khalili, 1992; Vacante et al.,
1989). A minimal ‘‘core promoter’’ comprising the 1–28 Interestingly, the Bpenta region, with the sequence 5*-
AGGGAAGGGA-3*, functions as an activator of the JCVregion on the viral genome appears to be insufficient to
direct the proper transcriptional initiation (Krebs et al., early promoter, but as a repressor of the JCV late pro-
moter (Tada et al., 1991; Tada and Khalili, 1992). Site-1995). Further analyses with purified TATA-binding pro-
teins or site-directed mutagenesis are needed to clarify directed mutagenesis indicates that these disparate
orientation-dependent activities map two distinct se-the functional importance of the TATA boxes for JCV early
transcription. Nevertheless, the A region appears to be quences within Bpenta and are probably mediated by dis-
tinct transcription factors (Tada et al., 1991; Tada andimportant for basal transcription and may confer some
glial specificity to the viral early promoter (Ahmed et al., Khalili, 1992). This element has also been shown to be
important for viral DNA replication, with mutations dis-1990a; Krebs et al., 1995; Tada et al., 1989). In contrast,
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abling the replicative ability of the viral DNA (Chang et to the C region and vice versa. Interestingly, unlike the
B region, the C region does not appear to play a signifi-al., 1994; Lynch and Frisque, 1990, 1991). Single-stranded
forms of the Bpenta region are the binding sites for the cant role in basal transcription (Ahmed et al., 1990a; Ku-
mar et al., 1993; Tamura et al., 1988a). This region iscellular factors, LCP-1 (50–52 kDa, 100–120 kDa), pur
a, and YB-1 (Chen et al., 1995; Kerr et al., 1994; Tada thought to represent potential binding sites for the NF-1
and perhaps the E4TF1 transcription factors (Amemiyaand Khalili, 1992). The Bpenta region, in a double-stranded
conformation, also serves as the target for a 56- to 60- et al., 1992).
The ‘‘D’’ region spans the sequences from 240 to 270kDa silencer protein (Tada et al., 1991).
The BNF1 site has been extensively characterized and on the viral promoter and contains a consensus NF-1
site, with the sequence 5* TGGCTTGTCACCA 3*. Thiscontains a consensus NF-1 binding site, 5* TGGC-
TGGCTGCCA 3 * (Amemiya et al., 1989, 1992; Kumar et region exhibits a high degree of protection in DNase I
footprinting experiments (Ahmed et al., 1990b; Amemiyaal., 1993; Nakshatri et al., 1990; Tamura et al., 1988a,b).
Site-directed mutagenesis of these NF-1 motifs dramati- et al., 1992) with protection over the NF-1 sites. The D
region contains a major transcription initiation start sitecally decreased transcriptional activity from the viral early
promoter both in vivo and in vitro (Kumar et al., 1993; of the viral late promoter (Rieckmann et al., 1994). The
D region on the early promoter is thought to function asTamura et al., 1988). The two BNF1 sites on adjacent 98-
bp repeats appear to cooperatively affect the binding of an activator (Ahmed et al., 1990a,b; Tada et al., 1989).
The D region represents a binding site for the cellularproteins to each individual site (Kumar et al., 1993). A
role in replication has also been proposed for the BNF1 transcription factors, NF-1, c-jun, and YB-1 (Amemiya et
al., 1992; Raj et al., unpublished observations).site, as evidenced by the ability of mutations in this NF-
1 site to reduce T-antigen-mediated viral DNA replication The ‘‘E’’ region corresponds to sequences from 270 to
310 on the viral promoter and also contains a potential(Sock et al., 1993). The BNF-1 site is the target for the
cellular proteins, NF-1, GF-1, and perhaps a SacI-motif NF-1 site (Amemiya et al., 1992). This region is present
in the leader sequences of most late viral RNA species.binding protein (Amemiya et al., 1992; Kerr and Khalili,
1991; Tamura et al., 1990). Interestingly, BNF1 sites are The functional role for this region is unknown, as most
analyses of the viral late gene expression were per-able to confer glial-specific expression to a heterologous
promoter construct (Amemiya et al., 1992). Further, the formed with constructs that lack the E region. The ratio-
nale for excluding the E region from these studies wasNF-1 site may represent a regulatory target for some
extracellular stimuli, like TGF-b1, but not for others, in- based on the archaic notion that sequences downstream
of the transcription initiation site do not contribute tocluding TNF-a, IL-2, IL-1b, or IL-6 (Atwood et al., 1992;
Rossi et al., 1988). transcriptional regulation. The putative enhancer function
of the E region as well as other sequences outside ofThe BAP1 site contains an AP-1-like sequence 5* TGT-
CACCA-3* (consensus 5* TGACATCA-3*) and has been the noncoding region warrants further examination.
Although the JCV Mad-1 isolate does not contain ashown to serve as a binding site for purified c-jun protein
(Amemiya et al., 1992). The proximity to the BNF1 site has consensus Sp1 site, other Sp1 sites are frequently seen
in PCR-based amplification of JCV sequences (Henson,been shown to modulate the interaction of proteins with
the BAP1 site. The BAP1 site may also represent another 1993). These sites have been shown to functionally con-
tribute to the transcription from the viral early or lateinducible element on the viral promoter; however, further
experimentation is required to confirm this hypothesis. promoter (Henson et al., 1992; Henson, 1993).
Taken together, these anthologies indicate the charac-The ‘‘Z’’ region represents sequences on the 98-bp
repeats between 71 and 109 (169 and 207) and contains terized role of each promoter region in either basal or
induced transcription or coupled with DNA replication.no consensus binding sites for any known transcription
factors, as indicated by computer-aided analyses (Fig. In general, the net promoter activity is likely to reflect the
collective contribution of each individual region as well2). Evidence for a transcriptional role for the Z region on
the viral promoter is indirect and reflects the ability of as the cooperativity between the various regions. Deter-
mination of the restricted glial specificity or inducibilityoligonucleotides spanning this region to sequester fac-
tors required for the transcription from the viral early of expression is probably a function of many distinct
promoter regions as well as the context of the viral pro-promoter (Ahmed et al., 1990a). The Z region contains
two copies of the CAAT box sequence and represents a moter.
potential Tst-1 binding site (Wegner et al., 1993).
The ‘‘C’’ region corresponds to sequences between ANALYSES OF THE ROLE OF trans FACTORS ON
208 and 240 on the viral genome and contains a pseudo- THE VIRAL PROMOTER
NF-1 site, with the sequence 5* TGGAAAGCAGCCA 3*.
This region shares some common transcription factors Distinct viral and cellular gene products have been
shown to regulate the expression of the viral promoterwith the B region, as evidenced by the ability of oligonu-
cleotides from the B region to compete for the binding by direct and/or indirect interaction with critical cis re-
/ m4171$7484 10-04-95 09:25:24 vira AP-Virology
287TRANSCRIPTIONAL REGULATION AND JCV
gions on the viral promoter. The individual contributions scription from both the viral early and late promoters
(Kerr and Khalili, 1991). GF-1 represents a partial lengthas well as the interplay between these factors may dic-
tate the expression of the viral early and late promoters. human homologue of the cloned murine Smbp-2 protein
(Mizutsa et al., 1993a,b). The full-length human GF-1 mayThe effects of several transcription factors on viral ex-
pression are individually detailed below. represent the 85/88 or the 230-kDa nucleoprotein com-
plex observed with the B region (Khalili et al., 1988). ItLike its well-characterized SV40 counterpart, the JCV
large T-antigen is a potent regulator of viral gene expres- remains to be seen if, like the partial-length clone, the
full-length version of GF-1 can bind to the B region andsion and does so at multiple levels (reviewed in Manfredi
and Prives, 1994; Mizutsa et al., 1993b). T-antigen binds enhance viral gene expression.
Another protein cloned by virtue of its ability to bindthe viral DNA directly at the origin and initiates bidirec-
tional viral DNA replication (Lynch and Frisque, 1990, the B region, the Y-box protein, YB-1, has since been
shown to interact with several pyrimidine stretches on1991; Tavis and Frisque, 1991; Tavis et al., 1994). JCV T-
antigen is a potent transactivator of the viral late, but the JCV promoter, including the Bpenta element, the OGRS
element, and the D region (Kerr et al., 1994; Raj et al.,not the early, promoter and is thought to be the primary
determinant of the switch in transcription initiation sites unpublished observations). YB-1 binds to both single-
and double-stranded DNA, which is intriguing since onefrom the early to the late phase of infection (Frisque and
White, 1992; Khalili et al., 1987; Lashgari et al., 1989). of its binding targets, the Bpenta element, lies within a
region of altered DNA conformation (Amirhaeri et al.,The binding of T-antigen to the viral origin of replication
is not required for its ability to transactivate the viral late 1987). YB-1 activates the transcription from both the viral
early and late promoter (Chen and Khalili, 1995; Kerr etpromoter (Chowdhury et al., 1990). T-antigen is thought
to indirectly modulate late gene expression, as a result al., 1994), a function attributed to both its interaction with
DNA and its ability to interact with other viral and cellularof cooperative interactions with several cellular proteins
that bind to the viral promoter, including YB-1 and Tst-1 proteins, including the large T-antigen, RelA, and pur a
(Chen et al., 1995; Chen and Khalili, 1995; Kerr et al.,(Gruda et al., 1993; Kerr et al., 1994; Renner et al., 1994).
Other characterized interactions of T-antigen with p53 1994; Raj et al., unpublished observations).
One of the cellular partners of YB-1, pur a, is a highly(which may bind to the JCV promoter), pRb, or the basal
transcriptional machinery may also contribute to the in- conserved protein that exhibits a high affinity for purine-
rich stretches (Bergemann and Johnson, 1992; Berge-creased transcription of the viral late promoter (Ariza et
al., 1994; Lammie et al., 1994). mann et al., 1992; Ma et al., 1994). pur a binds to several
regions on the JCV promoter, including the Bpenta element,The cellular factors that interact with the B region on
the viral promoter have been most extensively character- the OGRS element, and the D region, and activates tran-
scription from the viral early but not the late promoterized. Initial comparative analyses indicated the presence
of a 45-kDa glial-specific complex with the B region (Kha- (Chen and Khalili, 1995; Chen et al., 1995; Raj et al.,
unpublished observations). pur a, which has previouslylili et al., 1988). This 45-kDa species has been functionally
shown to be a transcriptional activator of the JCV early been shown to interact with a cellular origin of DNA
replication, has also been shown to have a negativepromoter and inducible in primary B lymphocytes, but its
identity remains a mystery (Ahmed et al., 1990a; Rieck- effect on viral DNA replication (Bergemann and Johnson,
1992; Chang et al., in preparation). In addition to YB-1,mann et al., 1994). The identity of some of the other B-
region-binding cellular factors is known, as NF-1, GF-1, pur a has also been shown to interact with the product of
the retinoblastoma gene, pRb, and the HIV-1 Tat proteinYB-1, pur a, and AP-1 have been shown to interact with
the B region. (Edward Johnson, Mt. Sinai, personal communication).
Additional proteins of 25–28, 50–52, 56, and 100–120Multiple NF-1 binding sites are present on the viral
promoter, including those within the B, C, D, and E re- kDa that bind to the Bpenta element have been demon-
strated to activate early gene expression and repressgions (see Fig. 2). A strong case can be made for the
role of the NF-1 binding sites in both transcriptional regu- late gene expression (Sharma and Kumar, 1991; Tada
et al., 1991; Tada and Khalili, 1992). The identity andlation and DNA replication (Ahmed et al., 1990a; Kumar
et al., 1993; Sock et al., 1991; Tamura et al., 1988a). Puri- relationship of these proteins to pur a and YB-1 is at
present unclear. Further, the presence of neighboring cisfied NF-1 has been shown to bind to this site (Chang et
al., 1994), but has not been shown to regulate transcrip- sequences appears to offer a more intricate network of
protein–protein interactions that dictate the identity oftion from the viral promoter. Related proteins with a DNA
binding specificity similar to that of NF-1 or other factors transcription factors bound to the B region (Kumar et al.,
1994).that interact with NF-1 via protein–protein interactions
may contribute to the basal transcriptional activity of the Another B-region-binding protein, c-jun, is a member
of the AP-1 family of inducible transcription factors. TheJCV promoter.
GF-1, a recombinant protein with a binding specificity binding of c-jun to the BAP1 site is modulated by NF-1
that binds to the adjacent BNF-1 site (Amemiya et al., 1992).similar to that of NF-1, has been shown to activate tran-
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The previously reported SacI-motif binding protein may variant JC viral PCR-amplified sequences have been
shown to exhibit consensus and functional Sp1 bindingbe c-jun, as evidenced by the similarity in their interaction
with NF-1 as well as in their binding to DNA (Amemiya sites (Henson et al., 1992). Interaction of Sp1 with its
binding site and these variant promoters has been dem-et al., 1992; Tamura et al., 1988a). However, a functional
activity for c-jun or other AP-1 family members upon inter- onstrated and appears to confer increased transcription
from the JC viral early promoter (Henson et al., 1992;action with the BAP1 region has not been documented.
Another family of inducible transcription factors, NF- Henson, 1993).
Compilation of these diverse individual analyses indi-kB, has been documented to play a role in determining
the basal and activated levels of transcription of the viral cates that the control of the viral early and late gene
expression is extremely complex. Redundancy is promi-early and late promoters (Ranganathan and Khalili, 1993).
The inducible relA (p65) subunit activates transcription nent, with duplication of promoter elements and multiple
binding sites for many transcription factors. Perhaps thefrom the NF-kB site, while the constitutive NF-kB1 (p50)
and NF-kB2 (p52) subunits activate transcription from the repetition of binding sites on the viral promoter is de-
signed to maximize the effect of a particular subset ofD domain (Raj et al., unpublished observations). Again,
these disparate activities appear to involve both direct transcription factors. Interestingly, some of these re-
peated elements appear to have distinct roles, with differ-DNA binding (p50, p52, and p65 bind to the NF-kB site) as
well as protein–protein interactions (interaction between ential transcriptional responses to the same transcription
factor. These differential responses may be partly deter-RelA and YB-1 on the D domain). The duality of JCV
transcriptional regulation by NF-kB may explain the abil- mined by the content of neighboring cis elements. Pro-
tein–protein interactions further complicate the regula-ity to increase both basal and activated levels of viral
transcription. tory scene and permit the same transcription factor to
both directly and indirectly influence viral gene expres-Like NF-kB, GBP-i represents a transcription factor
whose binding is dramatically enhanced by extracellular sion. Importantly, it must be noted that many of the tran-
scription factors that have been shown to interact withstimuli. GBP-i is an 81-kDa protein that binds to the OGRS
element within the viral origin of DNA replication. Unlike the JCV promoter, including the 45-kDa B-region-binding
protein, have not been identified. The intricate machineryNF-kB, GBP-i appears to function as an inducible tran-
scriptional repressor of viral early and late promoter ac- of JCV transcriptional regulation awaits further character-
ization.tivity (Atwood et al., 1992; Raj and Khalili, 1994).
Another regulator of viral early and late gene expres-
sion, Tst-1, is a well-characterized member of the POU CROSS-REGULATION OF VIRAL GENE
domain family that is expressed in a developmental- and EXPRESSION
tissue-specific manner. Tst-1 binds to distinct sequences
within the A and Z regions on the viral promoter (Fig. 2) The JC virus can be ‘‘efficiently’’ propagated in culture
only in glial cells; however, in comparison to other poly-(Wegner et al., 1993). Tst-1 has been shown to activate
both the viral early and late promoters by virtue of interac- omaviruses, even in glial cells, JCV titers are low, at-
testing to a very inefficient lytic cycle. This slow viral cycletion with the A region (Renner et al., 1994; Wegner et
al., 1993). In contrast, the Z region is unable to mediate does not appear to conform to the rapid progression
of the viral disease, PML. Cross-regulation of JCV byresponsiveness to Tst-1, indicating that additional speci-
ficity determinants may be present on the A region that additional factors, including cytokines and growth factors
associated with immunosuppression and helper viruses,enable Tst-1-mediated transcription (Krebs et al., 1995;
Wegner et al., 1993). Tst-1 physically interacts with the including HIV-1 and herpes, have been postulated to ac-
count for the discrepancy (Aksamit et al., 1990; von Ein-JC viral T-antigen, resulting in a synergistic activation of
both viral early and late promoters (Renner et al., 1994). siedel et al., 1993).
Cytokine and growth factors activate expression fromTst-1 has also been clearly shown to have no direct role
on JCV DNA replication (Wegner et al., 1993). both viral early and late promoters (Atwood et al., 1992;
Raj and Khalili, 1994; Reddy et al., in preparation) andThe role of another transcription factor, Sp1, in the
regulation of viral gene expression is largely unclear. are thought to mediate their effects by induction of tran-
scription factors like the 45-kDa protein, Rel A, GBP-i,The potential Sp1 binding site on the JCV Mad-1 promoter
(within the OGRS element) is both an HIV-1 Tat-responsive and potentially c-jun, NF-1, and YB-1, which in turn inter-
act with the B region NF-kB element, OGRS , BAP-1 , BNF-1 ,element and the target for a 90-kDa nucleoprotein com-
plex (Chowdhury et al., 1993). Since HIV-1 Tat has been and Bpenta elements on the viral promoter, respectively
(Atwood et al., 1992; Kerr et al., 1994; Raj and Khalili,shown to regulate the HIV promoter via Sp1, it is tempting
to speculate that the 90-kDa protein is Sp1. However, 1994; Ranganathan and Khalili, 1993; Rieckmann et al.,
1994).Sp1 has not been detected in a complex with this region
and purified Sp1 does not footprint any region on the HIV-1-encoded transregulatory protein, Tat, has been
shown to activate transcription from the JCV late pro-viral promoter (Amemiya et al., 1992). Interestingly, recent
/ m4171$7484 10-04-95 09:25:24 vira AP-Virology
289TRANSCRIPTIONAL REGULATION AND JCV
moter (Chowdhury et al., 1990; Remenick et al., 1991; moter, composed of multiple copies of JCV promoter or
highly neuroselective elements, may serve as a shuttleTada et al., 1990). Tat appears to mediate its regulation
of JCV promoter via two distinct regions on the viral pro- vector for gene therapy to oligodendroglia in multiple
sclerosis and other demyelinating diseases.moter, the OGRS element and the BCTAR element (Chow-
dhury et al., 1992, 1993). Tat may interact with the RNA Identification of cellular determinants of JCV neurotro-
pism may also lead to identification of oligodendrocyte-corresponding to the BCTAR element in a manner similar
to its interaction with HIV TAR (Chowdhury et al., 1992). specific genes or markers. These genes may play a role
in the function of oligodendrocytes, i.e., myelin produc-How Tat activates transcription from the OGRS element is
currently unclear (Chowdhury et al., 1993). tion, and thus serve as potential therapeutic targets.
Finally, the analyses on the transcriptional regulationInfection of fibroblasts with cytomegalovirus (CMV) in-
duces replication of a plasmid under the influence of the of papovaviral promoters offers a window into the regula-
tion of eukaryotic gene expression. Intricate interplay be-JCV origin of DNA replication (Heilbronn et al., 1993).
This effect may be secondary to an increase in transcrip- tween various transcription factors, involving protein–
protein and protein–DNA interactions, appears to care-tion from the viral early promoter invoked by CMV infec-
tion. Nonetheless, the data suggest a potential role for fully orchestrate the viral gene expression. The relatively
compact viral promoter offers a sophisticated system ofCMV and other helper viruses in abetting the expression
of JCV in both glial and nonglial cells. controlled gene expression and may facilitate the identifi-
cation of novel mechanisms involved in transcriptional
regulation.NEUROTROPISM OF THE JC VIRUS
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